Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

Clinical trial NCT05664789 · RECRUITING

Trial details

NCT number: NCT05664789
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2023-04-26
Primary completion: 2028-01-31
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.